LobbyingClick Therapeutics lobbying by quarter
Click Therapeutics's latest lobbying report covers Q2 2026, at $10K. The four quarters Q4 2025–Q3 2026 total $70K. Its first report covers Q2 2023; the issues it reports most are Health Issues and Medicare/Medicaid.
Click Therapeutics
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $70K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q2 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2023 | $0 | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $50K | 1 |
| Q3 2025 | $50K | 1 |
| Q4 2025 | $50K | 1 |
| Q1 2026 | $10K | 1 |
| Q2 2026 | $10K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$170K · 5 reports
- Medicare and Medicaid$0 · 4 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES9 reports
- SENATE9 reports
Firms it paid
| Firm | ||
|---|---|---|
| Hogan Lovells Cadwalader US | $170K | 5 quarters |
| Bluebird Strategies | $0 | 4 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| CYBIL G. ROEHRENBECK | Legislative Counsel to Office of Representative Walter B. Jones (2006 - 2010); Office of Representative J.C. Watts (2002) | Q2 2026 |
| DANIEL WINKLER | Legislative Fellow, Staff Assistant, Legislative Aide - Congresswoman Kyrsten Sinema (August 2015- January 2019); Advisor, Senior Advisor (paid under senior staff threshold) to Senator Kyrsten Sinema - January 2019 - January 2025 (paid under senior staff threshold) | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/15for Q2 | Hogan Lovells Cadwalader US | $10K |
| 04/13for Q1 | Hogan Lovells Cadwalader US | $10K |
| 01/20for Q4 2025 | Hogan Lovells Cadwalader US | $50K |
| 25/10/16for Q3 2025 | Hogan Lovells Cadwalader US | $50K |
| 25/07/16for Q2 2025 | Hogan Lovells Cadwalader US | $50K |
| 25/06/17for Q2 2025 | Hogan Lovells Cadwalader US | Under $5,000 |
| 24/04/23for Q1 2024 | Bluebird Strategies | Under $5,000 |
| 24/01/05for Q4 2023 | Bluebird Strategies | Under $5,000 |
| 23/10/19for Q3 2023 | Bluebird Strategies | Under $5,000 |
| 23/07/20for Q2 2023 | Bluebird Strategies | Under $5,000 |
| 23/07/19for Q2 2023 | Bluebird Strategies | Under $5,000 |